HLE Glascoat Ltd Q4 FY2026 Concall Summary

Key Takeaways

• Landmark year, margin miss: FY26 consolidated revenue grew 31.7% YoY to INR1,353 crores, but reported EBITDA margin of 11% fell well short of the 16% target, dragged by Omeras losses and exceptional items.
• Omeras at inflection point: The German subsidiary is very close to breakeven, its order book nearly doubled in Q4, and management expects double-digit standalone margins in FY27.
• Glass lined: volume up, value down: India glass lined equipment dispatched 30–40% more units, but revenue stayed flat at ~INR250 crores as value per equipment declined significantly.
• Geopolitics a fresh headwind: Demand recovery across specialty chemicals and CDMO was gaining traction until February, when geopolitical uncertainty began pushing clients to defer decisions.
• What to watch next quarter: Whether Omeras sustains its order book momentum into profitability, the pace of glass lined value recovery, and any easing of the geopolitical overhang on capex decisions.

Omeras Turnaround

• Near-breakeven achieved: Omeras is very close to breakeven, consistent with prior management communication; the order book almost doubled from December 2025 to March 2026, and the pipeline remains very strong.
• Management team rebuilt: A strong management team was assembled over the last six months, replacing prior leadership and setting the foundation for disciplined execution.
• Calibrated approach: The integration focused on execution quality, selective order acceptance and long-term sustainability; certain nonviable business segments were rationalized during the process.
• India capex underway: Investment in Indian manufacturing is focused initially on tanks for wastewater, pure water, semiconductors, food and biogas digesters; the architectural market is not yet mature enough in India. Commercial operations expected by end of FY27, with revenue in FY28.
• Market expansion sequenced: Step one is expanding Omeras' presence into other European countries; step two takes the product to the U.S. market.
• Synergy potential is real but slow: Customer overlap exists in India and abroad for the tank business; technology exchange opportunities with Thaletec and HLE are possible, but management cautions this is a long process, not an overnight unlock.

Nilesh Ganjwala: "Omeras is now very close to breakeven, which is exactly what we had expected and what we had communicated at that point in time. I think we expect over a period of time, maybe over the next 2 years to get into double-digit margin kind of business."

Glass Lined Equipment: The Volume-Value Disconnect

• Shop floor activity up, revenue flat: India glass lined equipment dispatched 30–40% more units over the past four years, but revenue remained flat at INR200–250 crores because value per equipment declined significantly.
• Thaletec adoption gaining traction: The Thaletec range introduced in India contributed ~20% of overall glass lined India products in FY26; management had estimated a 3–4 year mindset shift among users, and that shift is now materializing.
• Thaletec Germany subdued: Annual sales were more or less stagnant due to a slightly softer third quarter, with margins in low double digits (~11–11.5% EBIT); however, the current order book looks very encouraging and a turnaround is expected.
• U.S. as growth driver: The company has appointed more people in the U.S. and has been consistently getting orders for the last two years; the U.S. is expected to be a major growth driver for Thaletec.
• Utilization improving: Current glass lined utilization stands at 75%, up from 60–65% earlier; management did not directly confirm whether the 80% exit-quarter target was achieved.

Harsh Patel: "The cost per equipment that we used to get in '21, '22 was much different than what we are getting now. So, if you see the activity at the shop floor, the activity on the shop floor has actually increased. The number of equipment that we dispatch has actually increased by 30% to 40%. But the value per equipment has gone down to such an extent that you don't see the growth in the business."

Heat Transfer Equipment

• Stable year with oil & gas wins: Successful execution of oil and gas-related orders strengthened the track record and expanded the opportunity pipeline across domestic and international markets.
• Growth expectation of 15–20%: Management expects 15–20% growth in the heat transfer business for the next couple of years.
• Geopolitical upside pending: When the geopolitical situation settles, demand for heat exchangers is expected to jump meaningfully, though the timeline is uncertain.
• Capacity expansion on the horizon: The company will start looking at creating additional capacity from next year onwards, depending on how the current year progresses.
• Geographic expansion planned: India penetration strategy targets petrochemical and oil & gas sectors where HLE is a new entrant; the next phase is the Middle East, followed by the U.S.

Demand Environment & Geopolitical Overhang

• Pharma API driving demand: Most capex in India is happening in the pharma API sector, with custom manufacturing also seeing demand; specialty chemicals and agrochemicals remain subdued, though inquiry activity has improved selectively.
• Recovery interrupted: CDMO and agrochemical companies that were beginning to come back have again deferred some decisions due to the geopolitical situation that emerged in February.
• Gas price pass-through: Gas prices increased due to the recent conflict in Iran; the company has been able to pass on price increases to a large extent.
• Medium-term pharma capex tailwind: Large pharma capex announcements globally are expected to gradually translate into project execution over the medium term, positioning HLE to benefit.

Margins & Financials

• Reported vs adjusted margin: Reported EBITDA margin of 11% included an EBITDA loss of INR15.3 crores at Omeras, plus exceptional items of INR2.1 crores for New Labour Codes and INR4.6 crores for business acquisition costs; excluding Omeras, adjusted EBITDA margin for the ongoing business is close to 13.5%.
• 16% target deferred: Management expects to achieve 16% full-year EBITDA margins in the next two years; excluding Omeras, the ongoing business will be at 16%, while Omeras may drag the consolidated average down slightly.
• Consolidated margin band of 14–15%: The Indian business is expected to deliver 15%+ margins, while the Germany business delivers lower margins, pulling the consolidated figure into the 14–15% range.
• Revenue ambition: Management stated it would be disappointed if consolidated revenue is less than INR2,000 crores in two years, including Omeras.
• Dividend confidence: The board recommended a 55% dividend for FY26, reflecting confidence in long-term fundamentals and cash flow generation capabilities.

Strategy & Long-Term Positioning

• Technology-led, not me-too: The company will only enter segments or products where it has technology differentiation; it will not pursue me-too products.
• Global ambition: The stated goal is to become a technology-led global company, with Europe, the Middle East and the U.S. well positioned for expansion; a Middle East sales team was built before the conflict started.
• Integration capability proven: Having completed four acquisitions, the team has developed a good understanding of the integration process; all integrations have been smooth.
• Omeras FY27 revenue target: Management aims to get Omeras revenue well above INR200 crores in FY27; the order book and pipeline indicate this is achievable, though margins may not yet be at healthy double-digit levels.

Harsh Patel: "We will not go into me-too kind of products. Only and only if we have some technology differentiation, then we will enter a segment or a product."

Guidance & Commitments

Key Metrics